mitoxantrone and Cancer of Liver

mitoxantrone has been researched along with Cancer of Liver in 79 studies

Research

Studies (79)

TimeframeStudies, this research(%)All Research%
pre-199018 (22.78)18.7374
1990's29 (36.71)18.2507
2000's18 (22.78)29.6817
2010's11 (13.92)24.3611
2020's3 (3.80)2.80

Authors

AuthorsStudies
Hong, C; Li, Q; Luo, W; Su, Y; Wang, C; Wang, Y; Xie, S; Zhai, Y; Zhang, X; Zhao, J; Zhu, Z1
Guo, G; He, X; Li, J; Lin, Y; Liu, J; Xie, B; Zhang, X1
Czauderna, C; Galle, PR; Heil, E; Heinrich, B; Heinrich, S; Kloeckner, R; Koch, S; Marquardt, JU; Philippe P Diggs, L; Schmidtmann, I; Sprinzl, M; Weinmann, A; Wörns, MA1
Jia, M; Shao, L; Ye, Q1
Arai, Y; Furuse, J; Ikeda, M; Inaba, Y; Kobayashi, T; Mitsunaga, S; Morizane, C; Okusaka, T; Sato, Y; Ueno, H1
Guo, Y; Hu, Y; Huang, Y; Liu, D; Lu, B; Wang, X; Zhu, Z1
An, Y; Ding, Y; Han, Y; He, C; Jia, G; Tang, Q; Wang, X1
Kunda, NM; Maker, AV; Prabhakar, BS; Qiao, G; Qin, J; Tulla, K1
Chakraborty, G; Gorain, M; Kumar, D; Kumar, S; Kundu, GC; Sharma, P1
Di Pietro, A; Guterres, FA; Martinez, GR; Rocha, ME; Scoparo, CT; Valdameri, G; Winnischofer, SM; Worfel, PR1
Hagihara, A; Ikeda, M; Iwasa, S; Kojima, Y; Morizane, C; Okusaka, T; Ueno, H1
Liu, J; Sun, X; Zeng, L; Zhang, Z; Zhou, Q1
Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H1
Chen, HC; Hsu, CL; Hung, CF; Lin, CC; Pan, KT; Sung, CM; Tseng, JH; Yeh, CT1
Liang, KH; Lin, CC; Yeh, CT1
Fan, R; Gan, Y; Guo, S; Li, F; Yu, M; Zhang, X; Zhu, C1
Andreesen, R; Bodenstein, H; Clemens, M; Fehnle, K; Fischer, JT; Heidemann, E; Hirschmann, WD; Kaufmann, M; König, M; Mahlke, M; Oberhoff, C; Scharl, A; Schulze, M; Souchon, R; Stoeger, H1
Chang, HK; Chang, WC; Chen, JS; Liau, CT; Lin, YC; Yang, TS1
Ikeda, M; Okusaka, T; Ueno, H1
Ikeda, M; Morizane, C; Okusaka, T; Takezako, Y; Ueno, H1
Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA1
Akimoto, M; Ebara, M; Fukuda, H; Kondo, F; Saisho, H; Sato, T; Yoshikawa, M1
Enoki, T; Hamano, K; Harada, E; Kitada, K; Noshima, S1
Deguchi, K; Hamaguchi, J; Kamiyama, N; Kamiyama, T; Kudo, T; Nakagawa, H; Nakagawa, T; Nakanishi, K; Nishimura, S; Takahashi, M; Todo, S; Yokoo, H1
Aravantinos, G; Bafaloukos, D; Fountzilas, G; Gogas, H; Kalofonos, HP; Koutras, A; Makatsoris, T; Mantzourani, M; Markopoulos, C; Onyenadum, A; Tzorakoelefterakis, E; Xiros, N1
Dittrich, C; Dudczak, R; Lenzhofer, R; Moser, K; Pirker, P; Rainer, H; Schuster, R1
Coetzer, BJ; Falkson, G; Terblanche, AP1
Bedikian, AY; Bodey, GP; Karlin, D; Korinek, J; Stroehlein, J; Valdivieso, M1
Hirayama, R; Ichikawa, W; Kawachi, Y; Mishima, Y; Miyanaga, T; Nihei, Z; Osanai, T; Sawai, S; Togo, S; Yamashita, T1
Asaumi, S; Iino, Y; Ishikawa, H; Iwanami, K; Kawashima, K; Kobayashi, J; Kubota, K; Matsumoto, H; Morishita, Y; Yokoe, T1
Hou, SX; Liao, GT; Zhang, ZR1
Harima, K; Kawa, S; Murata, T; Nagata, K; Nishida, T; Okuda, M; Oshima, T; Seki, Y; Tanaka, Y; Uda, M1
Bai, S; Hou, S; Liao, G; Zhang, X; Zhang, Z1
Bai, S; Hou, S; Liao, G; Xie, C; Zhang, X; Zhang, Z1
Cherqui, D; Dhumeaux, D; Duvoux, C; Fagniez, PL; Julien, M; LeBourgeois, JP; Piedbois, P; Pierga, JY; Tran Van-Nhieu, J; Vavasseur, D1
Blanz, J; Ehninger, G; Gebhardt, R; Mewes, K; Zeller, KP1
Audisio, R; Bajetta, E; Bartoli, C; Bochicchio, AM; Bonfanti, G; Buzzoni, R; Colleoni, M; Nolè, F1
Abbruzzese, J; Ajani, JA; Carrasco, CH; Charnsangavej, C; Jones, DV; Levin, B; Patt, YZ; Wallace, S1
Aoyagi, H; Horiguchi, J; Iino, Y; Ishida, T; Maemura, M; Morishita, Y; Sugamata, N; Takai, Y; Yokoe, T1
Brambs, HJ; Brensing, KA; Görich, J; Kunze, V; Müller-Miny, H; Rilinger, N; Sokiranski, R1
Beger, HG; Leder, G; Link, KH; Pillasch, J; Weindel, M1
Hiraki, S; Maeda, Y; Nakashima, K; Nishida, M; Oka, M; Suzuki, T; Takao, K; Takao, T1
Colleoni, M; Liessi, G; Manente, P; Mastrapasqua, G; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G1
Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, GH; Lenz, HJ; Link, KH; Metzger, R; Pillasch, J; Safi, F; Weindel, M1
Hasegawa, M; Koyama, T; Manabe, K; Takagi, K1
Akagi, K; Kimura, H; Murata, T; Nagata, K; Nasu, R; Tanaka, Y; Uokawa, K1
Beger, HG; Butzer, U; Gansauge, F; Kornmann, M; Leder, GH; Link, KH; Pillasch, J; Staib, L1
Beger, HG; Kornmann, M; Leder, G; Link, KH; Pillasch, AF; Pressmar, J; Schatz, M; Sunelaitis, E1
Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M1
Bashey, A; Corringham, RE; Corringham, S; Garrett, J; Gilpin, EA; Ho, AD; Lane, TA; Law, P1
Fujii, S; Fukushi, Y; Futagami, M; Higuchi, T; Saito, Y; Sakamoto, T; Sato, S; Takami, H; Yokoyama, Y1
Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Salonga, D; Sunelaitis, E1
Dorey, F; Eilber, FC; Eilber, FR; Forscher, C; Nelson, SD; Rosen, G1
Carlson, LE; Glück, S; Koski, T1
Beger, HG; Formentini, A; Gansauge, F; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Schatz, M; Staib, L; Sunelaitis, E1
Auerbach, M; Elias, EG; Orford, J1
Bajetta, E; Colleoni, M; de Braud, F; Di Bartolomeo, M; Nole, F1
Hirayama, R; Ichikawa, W; Kawachi, Y; Mishima, Y; Nihei, Z; Sawai, S; Tamaru, H; Uetake, H; Yamashita, T1
Charlotte, F; Cherqui, D; Duvoux, C; Julien, M; Lauzet, JY; Le Péchoux, C; Mathieu, D; Métreau, JM; Piedbois, P; Rotman, N1
Aoki, K; Nose, H; Okada, S; Okazaki, N; Yoshimori, M1
Pestalozzi, B; Sauter, C; Schwendener, R1
Moriyama, N; Okada, S; Okazaki, N; Shimada, Y; Takayasu, K; Yoshida, T; Yoshino, M1
Du, MQ; Hutchinson, WL; Johnson, PJ; Williams, R1
Hartlapp, J; Heidemann, E; Hossfeld, D; Kunz, S; Neeser, E; Possinger, K; Schumacher, K; Steinke, B; von Ingersleben, G; Waldmann, R1
Lai, KH; Lee, SD; Lin, HC; Lin, HJ; Lo, GH; Ng, WW; Tam, TN; Teng, HC; Tsai, YT; Wu, JC1
Duthie, SJ; Grant, MH2
Coleman, RE; O'Reilly, SM; Rubens, RD1
Callender, ME; Clarke, R; Dickey, W; Johnston, GW; McAleer, JJ1
Carbone, PP; Coetzer, BJ; Creech, RH; Falkson, G; Johnson, LA; Ryan, LM; Schutt, AJ; Simson, IW1
Miyamoto, K; Ohkura, H; Okazaki, N; Shimada, Y; Yoshida, T; Yoshino, M1
Brook, MG; Dunk, AA; Goh, C; Lever, AM; McDonald, JA; Thomas, HC1
Dunk, AA; Johnson, PJ; Lok, AS; Melia, W; Murray-Lyon, I; Scott, SC; Thomas, HC; Williams, R1
Blackstein, ME; Evans, WK; Fine, S; Habal, F; Heathcote, J; Kutas, G; Langer, B; Pritchard, KI; Shepherd, FA; Taylor, B1
Bai, SH; Chen, XH; Tang, P; Xu, G1
Berkarda, B; Büyükünal, E; Derman, U; Serdengecti, S1
Davis, RB; Henderson, ES; Leone, LA; Van Echo, DA1
Coetzer, BJ; Falkson, G1

Reviews

3 review(s) available for mitoxantrone and Cancer of Liver

ArticleYear
[Chemotherapy for hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Mitoxantrone; Survival Rate; Tamoxifen

2004
Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Mitomycin; Mitoxantrone

1996
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Randomized Controlled Trials as Topic; Survival Analysis

1999

Trials

21 trial(s) available for mitoxantrone and Cancer of Liver

ArticleYear
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
    Japanese journal of clinical oncology, 2017, Jun-01, Volume: 47, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Treatment Outcome

2017
A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma.
    Nanomedicine : nanotechnology, biology, and medicine, 2009, Volume: 5, Issue:4

    Topics: Adult; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Nanomedicine; Nanoparticles; Survival Analysis; Treatment Outcome; Young Adult

2009
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:3

    Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cohort Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Peritoneal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil

2011
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Germany; Humans; Liver Neoplasms; Logistic Models; Lung Neoplasms; Middle Aged; Mitoxantrone; Neoplasm Staging; Probability; Proportional Hazards Models; Quality of Life; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Treatment Outcome

2002
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
    Cancer, 2005, Feb-15, Volume: 103, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis

2005
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome

2005
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Remission Induction; Salvage Therapy; Skin Neoplasms; Vinblastine; Vinorelbine

2007
[Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1994
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma.
    Cancer, 1993, Dec-01, Volume: 72, Issue:11

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Feasibility Studies; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Interferon-beta; Leukopenia; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Remission Induction; Survival Rate; Thrombocytopenia

1993
A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.
    Cancer, 1993, Nov-01, Volume: 72, Issue:9

    Topics: Adult; Aged; Carcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1993
Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinoma.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Survival Rate

1997
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
    Cancer letters, 1997, Sep-16, Volume: 118, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Colorectal Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; RNA, Messenger; Survival Rate; Thymidylate Synthase; Transcription, Genetic

1997
[Effect on hepatic function of hepatic artery infusion chemotherapy using epirubicin and mitoxantrone for advanced hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1998
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:9

    Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Prospective Studies; Tumor Stem Cell Assay

1996
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
    Bone marrow transplantation, 2000, Volume: 25, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Platelet Count; Soft Tissue Neoplasms; Survival Rate; Tamoxifen; Thiotepa; Transplantation, Autologous

2000
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
    Cancer, 2000, Jul-15, Volume: 89, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Folic Acid; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Predictive Value of Tests; Prospective Studies; Thymidylate Synthase; Treatment Outcome; Tumor Stem Cell Assay

2000
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
    Cancer, 2001, Dec-01, Volume: 92, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Survival Analysis; Treatment Outcome

2001
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer.
    Onkologie, 1990, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate

1990
A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study.
    Cancer, 1987, Nov-01, Volume: 60, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Evaluation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Prognosis; Random Allocation

1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomas.
    Alimentary pharmacology & therapeutics, 1987, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Child; Female; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1987
A clinical trial of mitoxantrone (novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast cancer.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neoplasm Metastasis

1987

Other Studies

55 other study(ies) available for mitoxantrone and Cancer of Liver

ArticleYear
Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Aspirin; Carcinoma, Hepatocellular; Cell Line; Flavonoids; Liver Neoplasms; Neoplasm Metastasis; Polyamines

2016
High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.
    Biochemical and biophysical research communications, 2020, 01-01, Volume: 521, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; High-Throughput Screening Assays; Humans; Liver Neoplasms; Mitoxantrone; Small Molecule Libraries; Tumor Cells, Cultured

2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
    United European gastroenterology journal, 2020, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular; Etoposide; Female; Germany; Humans; Ifosfamide; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Young Adult

2020
miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4.
    Journal of healthcare engineering, 2021, Volume: 2021

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; MicroRNAs; Mitoxantrone; Receptor, EphB4; Tumor Microenvironment

2021
Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Annexin A2; Anti-Bacterial Agents; Antineoplastic Agents; Azithromycin; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoroquinolones; Gemcitabine; Humans; Liver Neoplasms; Mitoxantrone; Moxifloxacin; Mycoplasma hyorhinis; Protein Binding; Real-Time Polymerase Chain Reaction

2017
Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma.
    Nanoscale, 2018, Apr-05, Volume: 10, Issue:14

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Epithelial Cell Adhesion Molecule; Female; Humans; Liver Neoplasms; Luminescence; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Mitoxantrone; Nanoparticles; Neoplasms, Experimental; Photochemotherapy; RAW 264.7 Cells; Theranostic Nanomedicine

2018
Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
    The Journal of surgical research, 2019, Volume: 233

    Topics: Animals; Antineoplastic Agents; Cancer Vaccines; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Female; Humans; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice; Mitoxantrone; Treatment Outcome

2019
Functional characterization of stromal osteopontin in melanoma progression and metastasis.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Animals; Carcinogenesis; Cell Communication; Cell Proliferation; Cell Separation; Disease Progression; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Liver Neoplasms; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Knockout; Mitoxantrone; Neoplastic Stem Cells; Neovascularization, Pathologic; Osteopontin; Phenotype; Side-Population Cells; Signal Transduction; Stromal Cells

2013
Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.
    Molecular and cellular biochemistry, 2015, Volume: 409, Issue:1-2

    Topics: Animals; Antioxidants; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flavones; Glutathione; HEK293 Cells; Hep G2 Cells; Humans; L Cells; Liver Neoplasms; Mice; Mitoxantrone; Multidrug Resistance-Associated Proteins; Plants, Medicinal; Reactive Oxygen Species; RNA, Messenger

2015
Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate; Treatment Outcome

2008
Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.
    BMC cancer, 2011, Mar-31, Volume: 11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Protocols; Disease Progression; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Retrospective Studies; Survival Analysis

2011
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC.
    Pharmacogenomics, 2011, Volume: 12, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Carcinoma, Hepatocellular; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Genome-Wide Association Study; Humans; Linkage Disequilibrium; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; N-Acetylgalactosaminyltransferases; Neoplasm Staging; Polymorphism, Single Nucleotide; Prospective Studies; Retrospective Studies

2011
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells.
    Biomaterials, 2012, Volume: 33, Issue:29

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Neoplasm Transplantation; Neoplasms; Polymers; Rats; Rats, Sprague-Dawley; Tissue Distribution

2012
Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Journal of gastroenterology, 2004, Volume: 39, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome

2004
Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma.
    World journal of gastroenterology, 2006, Feb-14, Volume: 12, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Carcinoma, Hepatocellular; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Immunohistochemistry; Infusions, Intra-Arterial; Liver Neoplasms; Mitoxantrone; Retrospective Studies

2006
[A case of multiple lung metastases of hepatocellular carcinoma after resection of liver and tumor thrombi in the inferior vena cava responding to chemotherapy using 5-FU, mitoxantrone and CDDP].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:2

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Neoplastic Cells, Circulating; Postoperative Period; Remission Induction; Vena Cava, Inferior

2007
N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.
    Molecular cancer, 2007, May-09, Volume: 6

    Topics: Antibiotics, Antineoplastic; Carbohydrate Sequence; Carcinoma, Hepatocellular; Down-Regulation; Drug Resistance, Neoplasm; Drug Tolerance; Epirubicin; Fucosyltransferases; Glycosylation; Glycosyltransferases; Humans; Liver Neoplasms; Mitoxantrone; N-Acetylglucosaminyltransferases; Oligosaccharides, Branched-Chain; Polysaccharides; Tumor Cells, Cultured; Up-Regulation

2007
[Mitoxantrone in the primary treatment of metastasizing breast cancer].
    Wiener klinische Wochenschrift, 1984, Apr-27, Volume: 96, Issue:9

    Topics: Aged; Alopecia; Anthraquinones; Brain Neoplasms; Breast Neoplasms; Drug Tolerance; Electrocardiography; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Skin Neoplasms; Time Factors

1984
Phase II trial of mitoxantrone in patients with primary liver cancer.
    Cancer treatment reports, 1984, Volume: 68, Issue:10

    Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1984
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary report.
    American journal of clinical oncology, 1983, Volume: 6, Issue:4

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Pancreatic Neoplasms; Platelet Count; Stomach Neoplasms; Thrombocytopenia

1983
[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14

    Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Ovariectomy

1994
[Study on mitoxantrone polycyanoacrylate nanospheres].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1994, Volume: 29, Issue:7

    Topics: Animals; Cyanoacrylates; Drug Carriers; Humans; Liver Neoplasms; Mice; Mice, Nude; Microspheres; Mitoxantrone; Neoplasm Transplantation

1994
[Clinical study of cyclic intra-arterial chemotherapy using mitoxantrone for advanced hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1994
[An observation of the anticarcinogenic effect of mitoxantrone-polybutylcyanoacrylate-nanosperes].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1993, Volume: 24, Issue:4

    Topics: Animals; Carcinoma, Hepatocellular; Drug Carriers; Drug Delivery Systems; Enbucrilate; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microspheres; Mitoxantrone; Neoplasm Transplantation

1993
[A model of orthotopic transplantation of human hepatoma established in nude mice tumor inhibition studies].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1993, Volume: 24, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitoxantrone; Neoplasm Transplantation

1993
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study.
    Cancer, 1994, Jun-01, Volume: 73, Issue:11

    Topics: Adult; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects

1994
Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates.
    Cancer research, 1993, Nov-01, Volume: 53, Issue:21

    Topics: Animals; Bile; Biotransformation; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Humans; Kinetics; Liver; Liver Neoplasms; Male; Mass Spectrometry; Mitoxantrone; Molecular Structure; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured

1993
[Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Salvage Therapy; Skin Neoplasms

1993
[Percutaneous drainage of refractory necrotizing tumors: experience in 9 patients].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 163, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cystadenocarcinoma; Drainage; Female; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Necrosis; Neoplasm Recurrence, Local; Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Sclerotherapy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterine Neoplasms

1995
[Effects of intra-hepatic arterial injection of mitoxantrone for hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Drug Administration Schedule; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitoxantrone

1996
[The effect of hepatic arterial infusion chemotherapy on the prognosis after hepatectomy for hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:4

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Prognosis; Retrospective Studies

1998
[A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:8

    Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Tamoxifen

1999
Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2000, Volume: 263, Issue:4

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liver Neoplasms; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Prednisolone; Remission Induction; Reoperation

2000
Recurrent gastrointestinal stromal sarcomas.
    Surgical oncology, 2000, Volume: 9, Issue:2

    Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Gastrointestinal Neoplasms; Humans; Injections, Intraperitoneal; Liver Neoplasms; Male; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Treatment Outcome

2000
Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer.
    Bone marrow transplantation, 2001, Volume: 27, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Arthralgia; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Depression; Female; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Longitudinal Studies; Lung Neoplasms; Middle Aged; Mitoxantrone; Paclitaxel; Quality of Life; Surveys and Questionnaires; Time Factors; Transplantation, Autologous

2001
Experience with methotrexate, 5-fluorouracil, and leucovorin (MFL): a first line effective, minimally toxic regimen for metastatic breast cancer.
    Cancer investigation, 2002, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Prospective Studies

2002
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factors.
    Oncology, 1992, Volume: 49, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Prognosis

1992
[Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl

    Topics: Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Therapy, Combination; Emulsions; Humans; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1992
[Liver transplantation associated with combined adjuvant treatment in hepatocellular carcinoma. Feasibility and preliminary results].
    Presse medicale (Paris, France : 1983), 1992, Dec-02, Volume: 21, Issue:41

    Topics: Adult; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Doxorubicin; Embolization, Therapeutic; Female; Humans; Iodized Oil; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mitoxantrone; Postoperative Care; Preoperative Care; Prospective Studies

1992
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
    Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:1

    Topics: alpha-Fetoproteins; Analysis of Variance; Antineoplastic Agents; Ascites; Bilirubin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Interferon-gamma; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Prognosis; Regression Analysis; Risk Factors; Serum Albumin; Tegafur; Time Factors

1992
Phase I/II study of liposome-complexed mitoxantrone in patients with advanced breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:6

    Topics: Adenocarcinoma; Agranulocytosis; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation; Female; Humans; Liposomes; Liver Neoplasms; Mitoxantrone

1992
Changes in mode of response to chemotherapy for hepatocellular carcinoma induced by transarterial embolization. A case report.
    Japanese journal of clinical oncology, 1991, Volume: 21, Issue:1

    Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Remission Induction; Tomography, X-Ray Computed

1991
Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
    Clinical science (London, England : 1979), 1991, Volume: 81, Issue:2

    Topics: Adult; Aged; alpha-Fetoproteins; alpha-L-Fucosidase; Carcinoma, Hepatocellular; Doxorubicin; Female; Glycoside Hydrolases; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mitoxantrone

1991
Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Evaluation; Female; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1989
The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells.
    Biochemical pharmacology, 1989, Apr-15, Volume: 38, Issue:8

    Topics: Adult; Biotransformation; Carcinoma, Hepatocellular; Cell Survival; Epoxide Hydrolases; Glutathione; Glutathione Transferase; Humans; Inactivation, Metabolic; Liver Neoplasms; Mitoxantrone; Oxidation-Reduction; Oxidoreductases; Tumor Cells, Cultured; Vitamin K

1989
The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells.
    British journal of cancer, 1989, Volume: 60, Issue:4

    Topics: Carcinoma, Hepatocellular; Doxorubicin; Humans; Liver Neoplasms; Mitoxantrone; Oxidation-Reduction; Tumor Cells, Cultured; Vitamin K

1989
Phase II study of mitoxantrone for liver metastases from breast cancer.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1

    Topics: Bone Marrow; Breast Neoplasms; Depression, Chemical; Drug Evaluation; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Mitoxantrone; Time Factors

1989
Regional lipiodolized chemotherapy for cholangiocarcinoma associated with oral contraceptives.
    Postgraduate medical journal, 1987, Volume: 63, Issue:741

    Topics: Adenoma, Bile Duct; Adult; Antineoplastic Combined Chemotherapy Protocols; Common Bile Duct Neoplasms; Contraceptives, Oral, Combined; Diatrizoate; Diatrizoate Meglumine; Doxorubicin; Female; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Mitoxantrone

1987
Phase II trial of mitoxantrone in patients with hepatocellular carcinoma.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:12

    Topics: Aged; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Thrombocytopenia

1988
Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.
    Journal of hepatology, 1985, Volume: 1, Issue:4

    Topics: Adult; Aged; Anthraquinones; Carcinoma, Hepatocellular; Child; Drug Evaluation; Female; Heart Diseases; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Thrombocytopenia

1985
Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1987
[A study of antineoplastic activity of DHAQ on human adenocarcinoma cells of lung hepatoma and gastric cancer cells in vitro].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1986, Volume: 17, Issue:4

    Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Cell Line; Humans; Liver Neoplasms; Lung Neoplasms; Mitotic Index; Mitoxantrone; Stomach Neoplasms; Tumor Stem Cell Assay

1986
Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:9

    Topics: Adolescent; Adult; Aged; Anthraquinones; Drug Evaluation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitoxantrone

1986
Mitozantrone.
    Drug and therapeutics bulletin, 1986, Sep-08, Volume: 24, Issue:18

    Topics: Breast Neoplasms; Humans; Leukemia; Liver Neoplasms; Lymphoma; Mitoxantrone; Neoplasms

1986
Phase II studies of mitoxantrone in patients with primary liver cancer.
    Investigational new drugs, 1985, Volume: 3, Issue:2

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Humans; Leukopenia; Liver Neoplasms; Middle Aged; Mitoxantrone; Thrombocytopenia

1985